{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T03:47:40Z","timestamp":1740109660823,"version":"3.37.3"},"reference-count":59,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100009647","name":"MOH","doi-asserted-by":"publisher","award":["600-RMI\/FRGS 5\/3 (111\/2014)","600-RMI\/RAGS 5\/3 (46\/2014)"],"award-info":[{"award-number":["600-RMI\/FRGS 5\/3 (111\/2014)","600-RMI\/RAGS 5\/3 (46\/2014)"]}],"id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/j.ejphar.2019.01.059","type":"journal-article","created":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T16:52:04Z","timestamp":1549039924000},"page":"75-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"special_numbering":"C","title":["Intraocular pressure-lowering effects of imidazo[1,2-a]- and pyrimido[1,2-a]benzimidazole compounds in rats with dexamethasone-induced ocular hypertension"],"prefix":"10.1016","volume":"850","author":[{"given":"Adrian Julian","family":"Marcus","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Igor","family":"Iezhitsa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renu","family":"Agarwal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pavel","family":"Vassiliev","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander","family":"Spasov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olga","family":"Zhukovskaya","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vera","family":"Anisimova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nafeeza Mohd","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"21","key":"10.1016\/j.ejphar.2019.01.059_bib1","doi-asserted-by":"crossref","first-page":"6071","DOI":"10.1016\/j.bmc.2017.09.045","article-title":"Design and synthesis of benzimidazole-based Rho kinase inhibitors for the treatment of glaucoma","volume":"25","author":"Abbhi","year":"2017","journal-title":"Bioorg. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejphar.2019.01.059_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000246571","article-title":"Future target molecules in antiglaucoma therapy: TGF-beta may have a role to play","volume":"43","author":"Agarwal","year":"2010","journal-title":"Ophthalmic Res."},{"issue":"3","key":"10.1016\/j.ejphar.2019.01.059_bib3","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1080\/17460441.2017.1281244","article-title":"Rodent models of glaucoma and their applicability for drug discovery","volume":"12","author":"Agarwal","year":"2017","journal-title":"Expert Opin. Drug Discov."},{"issue":"2","key":"10.1016\/j.ejphar.2019.01.059_bib4","first-page":"238","article-title":"Topical losartan reduces IOP by altering TM morphology in rats with steroid-induced ocular hypertension","volume":"62","author":"Agarwal","year":"2018","journal-title":"Indian J. Physiol. Pharmacol."},{"issue":"7","key":"10.1016\/j.ejphar.2019.01.059_bib5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/BF02508707","article-title":"Synthesis and study of the hypotensive and antiarrhythmic activity of 2,9-disubstituted 3-alkoxycarbonylimidazo[1,2-a]benzimidazoles","volume":"33","author":"Anisimova","year":"1999","journal-title":"Pharm. Chem. J."},{"issue":"9","key":"10.1016\/j.ejphar.2019.01.059_bib6","doi-asserted-by":"crossref","DOI":"10.1023\/A:1021888520874","article-title":"Synthesis and pharmacological activity of 1-N-and10-N-substituted 1(10),2,3,4-tetrahydropyrimido-[1,2-a]benzimidazoles","volume":"36","author":"Anisimova","year":"2002","journal-title":"Pharm. Chem. J."},{"issue":"11","key":"10.1016\/j.ejphar.2019.01.059_bib7","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s11094-006-0024-8","article-title":"Synthesis and pharmacological activityof 2-methoxyphenyl- and 2-oxyphenyl-substituted 1-dialkylaminoalkylimidazo[1,2-a]-benzimidazoles","volume":"39","author":"Anisimova","year":"2005","journal-title":"Pharm. Chem. J."},{"issue":"9","key":"10.1016\/j.ejphar.2019.01.059_bib8","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s11094-006-0005-y","article-title":"Synthesis and pharmacological activity of 2-methoxyphenyl-substituted 9-dialkylaminoethylimidazo[1,2-a]benzimidazoles","volume":"39","author":"Anisimova","year":"2005","journal-title":"Pharm. Chem. J."},{"issue":"12","key":"10.1016\/j.ejphar.2019.01.059_bib9","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1023\/A:1023421709976","article-title":"Synthesis and pharmacological activity of 3-aroyl-and3-hetaroylimidazo[1,2-a]benzimidazoles","volume":"36","author":"Anisimova","year":"2002","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ejphar.2019.01.059_bib10","unstructured":"Association for Research in Vision and Ophthalmology (ARVO). The statement for the use of animals in ophthalmic and vision research, http:\/\/arvo-prod.serverside.net\/About_ARVO\/Policies\/Statement_for_the_Use_of_Animals_in_Ophthalmic_and_Visual_Research\/ (accessed 26 February 2018)."},{"issue":"17","key":"10.1016\/j.ejphar.2019.01.059_bib11","doi-asserted-by":"crossref","first-page":"5191","DOI":"10.1016\/j.bmcl.2009.07.022","article-title":"4-(Benzimidazol-2-yl)-1,2,5-oxadiazol-3-ylamine derivatives: potent and selective p70S6 kinase inhibitors","volume":"19","author":"Bandarage","year":"2009","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"21","key":"10.1016\/j.ejphar.2019.01.059_bib12","doi-asserted-by":"crossref","first-page":"6208","DOI":"10.1016\/j.bmc.2012.09.013","article-title":"The therapeutic journey of benzimidazoles: a review","volume":"20","author":"Bansal","year":"2012","journal-title":"Bioorg. Med. Chem."},{"issue":"10","key":"10.1016\/j.ejphar.2019.01.059_bib13","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.2174\/13895575113139990072","article-title":"Novel research strategies of benzimidazole derivatives: a review","volume":"13","author":"Barot","year":"2013","journal-title":"Mini Rev. Med. Chem."},{"issue":"5","key":"10.1016\/j.ejphar.2019.01.059_bib14","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.exer.2005.01.028","article-title":"Cochlin deposits in the trabecular meshwork of the glaucomatous DBA\/2J mouse","volume":"80","author":"Bhattacharya","year":"2005","journal-title":"Exp. Eye Res."},{"issue":"4","key":"10.1016\/j.ejphar.2019.01.059_bib15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2174\/1389557053544047","article-title":"Imidazole and benzimidazole derivatives as chemotherapeutic agents","volume":"5","author":"Boiani","year":"2005","journal-title":"Mini Rev. Med. Chem."},{"issue":"1","key":"10.1016\/j.ejphar.2019.01.059_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1517\/13543784.2013.840288","article-title":"Rho-kinase inhibitors offer a new approach in the treatment of glaucoma","volume":"23","author":"Challa","year":"2014","journal-title":"Expert Opin. Investig. Drugs"},{"key":"10.1016\/j.ejphar.2019.01.059_bib17","unstructured":"ChemAxon: Software Solutions and Services for Chemistry & Biology, \u3008https:\/\/chemaxon.com\/\u3009."},{"issue":"11","key":"10.1016\/j.ejphar.2019.01.059_bib18","doi-asserted-by":"crossref","first-page":"7336","DOI":"10.1167\/iovs.12-10216","article-title":"Correlation of endothelin-1 concentration in aqueous humor with intraocular pressure in primary open angle and pseudoexfoliation glaucoma","volume":"53","author":"Choritz","year":"2012","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"issue":"11","key":"10.1016\/j.ejphar.2019.01.059_bib19","doi-asserted-by":"crossref","first-page":"3361","DOI":"10.1016\/j.bmcl.2010.04.020","article-title":"Benzothiophene containing Rho kinase inhibitors: efficacy in an animal model of glaucoma","volume":"20","author":"Davis","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"year":"2001","series-title":"Antidiabetic activity of benzimidazole derivatives. [Protivodiabeticheskaya aktivnost' proizvodnykh benzimidazola]","author":"Dudchenko","key":"10.1016\/j.ejphar.2019.01.059_bib20"},{"issue":"2","key":"10.1016\/j.ejphar.2019.01.059_bib21","first-page":"66","article-title":"Prediction of biological activity spectrum for organic compounds","volume":"50","author":"Filimonov","year":"2006","journal-title":"Ross. Khim. Zhurn. (Zhurn. Ross. Khim. Ob.-va Im. D. I. Mendeleeva)"},{"issue":"3","key":"10.1016\/j.ejphar.2019.01.059_bib22","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s10593-014-1496-1","article-title":"Prediction of the biological activity spectra of organic compounds using the PASS online web resource","volume":"50","author":"Filimonov","year":"2014","journal-title":"Chem. Heterocyc. Compd."},{"key":"10.1016\/j.ejphar.2019.01.059_bib23","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.ejmech.2014.01.030","article-title":"Benzimidazole: an emerging scaffold for analgesic and anti-inflammatory agents","volume":"76","author":"Gaba","year":"2014","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2019.01.059_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.preteyeres.2013.05.002","article-title":"Rho-associated kinase inhibitors: a novel glaucoma therapy","volume":"37","author":"Inoue","year":"2013","journal-title":"Prog. Retin. Eye Res."},{"key":"10.1016\/j.ejphar.2019.01.059_bib25","unstructured":"Inte:ligand: Advanced Molecular Design, \u3008http:\/\/www.inteligand.com\/\u3009."},{"issue":"1","key":"10.1016\/j.ejphar.2019.01.059_bib26","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/cbdd.12462","article-title":"Comprehensive review in current developments of benzimidazole-based medicinal chemistry","volume":"86","author":"Keri","year":"2015","journal-title":"Chem. Biol. Drug Des."},{"year":"2005","series-title":"Antioxidant agents: selection strategy, prospects of application [Antioksidantnyye sredstva: strategiya otbora, perspektivy primeneniya]","author":"Kosolapov","key":"10.1016\/j.ejphar.2019.01.059_bib27"},{"key":"10.1016\/j.ejphar.2019.01.059_bib28","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.ejps.2017.12.015","article-title":"Intraocular pressure lowering effect and structure-activity relationship of imidazo[1,2-a]benzimidazole and pyrimido[1,2-a]benzimidazole compounds in ocular normotensive rats: Insight on possible link with hypotensive activity","volume":"114","author":"Marcus","year":"2018","journal-title":"Eur. J. Pharm. Sci."},{"key":"10.1016\/j.ejphar.2019.01.059_bib29","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.dib.2018.03.019","article-title":"Data on the effects of imidazo[1,2-a]benzimidazole and pyrimido[1,2-a]benzimidazole compounds on intraocular pressure of ocular normotensive rats","volume":"18","author":"Marcus","year":"2018","journal-title":"Data Brief"},{"key":"10.1016\/j.ejphar.2019.01.059_bib30","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1007\/s10384-007-0507-5","article-title":"Proteomic analysis of rat retina in a steroid-induced ocular hypertension model: potential vulnerability to oxidative stress","volume":"52","author":"Miyara","year":"2008","journal-title":"Jpn. J. Ophthalmol."},{"key":"10.1016\/j.ejphar.2019.01.059_bib31","unstructured":"MOPAC: Stewart Computational Chemistry, \u3008http:\/\/openmopac.net\/\u3009."},{"issue":"6","key":"10.1016\/j.ejphar.2019.01.059_bib32","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.freeradbiomed.2004.06.001","article-title":"Retinal oxidative stress induced by high intraocular pressure","volume":"37","author":"Moreno","year":"2004","journal-title":"Free Radic. Biol. Med."},{"year":"1996","series-title":"Pharmacology of condensed benzimidazole antioxidants. [Farmakologiya antioksidantov kondensirovannykh proizvodnykh benzimidazola]","author":"Ostrovski\u012d","key":"10.1016\/j.ejphar.2019.01.059_bib33"},{"issue":"4","key":"10.1016\/j.ejphar.2019.01.059_bib34","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.ajpath.2016.12.003","article-title":"Dexamethasone-induced ocular hypertension in mice: effects of myocilin and route of administration","volume":"187","author":"Patel","year":"2017","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.ejphar.2019.01.059_bib35","unstructured":"PDBe: Protein Data Bank in Europe, \u3008http:\/\/www.ebi.ac.uk\/pdbe\/\u3009."},{"issue":"1","key":"10.1016\/j.ejphar.2019.01.059_bib36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.bmcl.2010.11.060","article-title":"Fragment-based discovery of 6-substituted isoquinolin-1-amine based ROCK-I inhibitors","volume":"21","author":"Ray","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2019.01.059_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejphar.2018.08.035","article-title":"IOP lowering effect of topical trans-resveratrol involves adenosine receptors and TGF-\u03b22 signaling pathways","volume":"838","author":"Razali","year":"2018","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.01.059_bib38","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejphar.2014.11.029","article-title":"Anterior and posterior segment changes in rat eyes with chronic steroid administration and their responsiveness to antiglaucoma drugs","volume":"749","author":"Razali","year":"2015","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejphar.2019.01.059_bib39","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.exer.2015.09.014","article-title":"Topical trans-resveratrol ameliorates steroid-induced anterior and posterior segment changes in rats","volume":"143","author":"Razali","year":"2016","journal-title":"Exp. Eye Res."},{"issue":"1","key":"10.1016\/j.ejphar.2019.01.059_bib40","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/ceo.12375","article-title":"Role of adenosine receptors in resveratrol-induced intraocular pressure lowering in rats with steroid-induced ocular hypertension","volume":"43","author":"Razali","year":"2015","journal-title":"Clin. Exp. Ophthalmol."},{"key":"10.1016\/j.ejphar.2019.01.059_bib41","doi-asserted-by":"crossref","first-page":"261386","DOI":"10.1155\/2013\/261386","article-title":"New therapeutic targets for intraocular pressure lowering","volume":"2013","author":"Rocha-Sousa","year":"2013","journal-title":"ISRN Ophthalmol."},{"issue":"1","key":"10.1016\/j.ejphar.2019.01.059_bib42","doi-asserted-by":"crossref","DOI":"10.1002\/jbt.22009","article-title":"Novel N-propylphthalimide- and 4-vinylbenzyl-substituted benzimidazole salts: synthesis, characterization, and determination of their metal chelating effects and inhibition profiles against acetylcholinesterase and carbonic anhydrase enzymes","volume":"32","author":"Sar\u0131","year":"2018","journal-title":"J. Biochem. Mol. Toxicol."},{"key":"10.1016\/j.ejphar.2019.01.059_bib43","unstructured":"Selleck Chemicals: Inhibitor Expert, \u3008http:\/\/www.selleckchem.com\/\u3009."},{"issue":"6","key":"10.1016\/j.ejphar.2019.01.059_bib44","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.bmcl.2010.01.124","article-title":"The development of benzimidazoles as selective rho kinase inhibitors","volume":"20","author":"Sessions","year":"2010","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"24","key":"10.1016\/j.ejphar.2019.01.059_bib45","doi-asserted-by":"crossref","first-page":"6390","DOI":"10.1016\/j.bmcl.2008.10.095","article-title":"Benzimidazole- and benzoxazole-based inhibitors of Rho kinase","volume":"18","author":"Sessions","year":"2008","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"2","key":"10.1016\/j.ejphar.2019.01.059_bib46","doi-asserted-by":"crossref","first-page":"98","DOI":"10.2174\/1871523014666150528110703","article-title":"A comprehensive review on recent advances in synthesis & pharmacotherapeutic potential of benzothiazoles","volume":"14","author":"Seth","year":"2015","journal-title":"Antiinflamm. Antiallergy Agents Med. Chem."},{"issue":"10","key":"10.1016\/j.ejphar.2019.01.059_bib47","first-page":"22","article-title":"Relationship between spasmolytic and gastroprotector properties of benzimidazole derivatives and their anticalmodulin activity","volume":"32","author":"Spasov","year":"1998","journal-title":"Khim.-Farm. Zh."},{"issue":"3","key":"10.1016\/j.ejphar.2019.01.059_bib48","first-page":"233","article-title":"Pharmacokinetics of benzimidazole derivatives","volume":"48","author":"Spasov","year":"2002","journal-title":"Vopr. Med. Khim."},{"issue":"5","key":"10.1016\/j.ejphar.2019.01.059_bib49","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1007\/BF02510042","article-title":"Benzimidazole derivatives: spectrum of pharmacological activity and toxicological properties (a review)","volume":"33","author":"Spasov","year":"1999","journal-title":"Pharm. Chem. J."},{"key":"10.1016\/j.ejphar.2019.01.059_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2018.04.040","article-title":"Rho kinase inhibitors as a novel treatment for glaucoma and ocular hypertension","author":"Tanna","year":"2018","journal-title":"Ophthalmology"},{"key":"10.1016\/j.ejphar.2019.01.059_bib51","unstructured":"Tocris Bioscience: High Performance Life Science Reagents, \u3008https:\/\/www.tocris.com\/\u3009."},{"issue":"2","key":"10.1016\/j.ejphar.2019.01.059_bib52","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1002\/jcc.21334","article-title":"AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading","volume":"31","author":"Trott","year":"2010","journal-title":"J. Comput. Chem."},{"key":"10.1016\/j.ejphar.2019.01.059_bib53","unstructured":"UniProtKB: UniProt Consortium, \u3008https:\/\/www.uniprot.org\/\u3009."},{"key":"10.1016\/j.ejphar.2019.01.059_bib54","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.dib.2018.02.067","article-title":"Relationship between intraocular pressure lowering effect and chemical structure of imidazo[1,2-a]benzimidazole and pyrimido[1,2-a]benzimidazole derivatives","volume":"18","author":"Vassiliev","year":"2018","journal-title":"Data Brief"},{"key":"10.1016\/j.ejphar.2019.01.059_bib55","article-title":"Consensus Drug Design Using IT Microcosm","volume":"17","author":"Vassiliev","year":"2014"},{"year":"2009","series-title":"Information technology for predicting the pharmacological activity of chemical compounds. [Informatsionnaya tekhnologiya prognoza formakologicheskoy aktivnosti khimicheskikh soyedineniy]","author":"Vassiliev","key":"10.1016\/j.ejphar.2019.01.059_bib56"},{"key":"10.1016\/j.ejphar.2019.01.059_bib57","doi-asserted-by":"crossref","unstructured":"Vecino E., Sharma S.C., November 11th 2011. Glaucoma Animal Models, Glaucoma Shimon Rumelt, IntechOpen,\u3008 https:\/\/doi.org\/10.5772\/18498\u3009 available from: \u3008https:\/\/www.intechopen.com\/books\/glaucoma-basic-and-clinical-concepts\/glaucoma-animal-modelsb\u3009.","DOI":"10.5772\/18498"},{"key":"10.1016\/j.ejphar.2019.01.059_bib58","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/j.ejmech.2014.11.053","article-title":"Structure activity relationship (SAR) study of benzimidazole scaffold for different biological activities: a mini-review","volume":"97","author":"Yadav","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejphar.2019.01.059_bib59","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.exer.2006.09.022","article-title":"Dexamethasone inhibition of trabecular meshwork cell phagocytosis and its modulation by glucocorticoid receptor beta","volume":"84","author":"Zhang","year":"2007","journal-title":"Exp. Eye Res."}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919300822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299919300822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T13:58:10Z","timestamp":1720965490000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299919300822"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,5]]},"references-count":59,"alternative-id":["S0014299919300822"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.01.059","relation":{},"ISSN":["0014-2999"],"issn-type":[{"type":"print","value":"0014-2999"}],"subject":[],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intraocular pressure-lowering effects of imidazo[1,2-a]- and pyrimido[1,2-a]benzimidazole compounds in rats with dexamethasone-induced ocular hypertension","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2019.01.059","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}